NVO241220P134000
- 0.00
- 0.000.00%
Novo-Nordisk A/S Newsroom
Cash / Money Market reserves may reach 80 billion USD! Novo-Nordisk A/S (NVO.US) and Eli Lilly and Co (LLY.US) are expected to initiate a merger and acquisition frenzy.
Novo-Nordisk A/S and Eli Lilly and Co (LLY.US), two pharmaceutical giants that have achieved great success in the field of weight loss drugs, may trigger a wave of large-scale mergers and acquisitions in 2025.
Express News | Investing 8.5 billion Danish kroner, Novo-Nordisk A/S plans to build a new factory in Denmark.
Is Novo Nordisk A/S (NVO) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
Novo Nordisk's Hiring Binge Leaves Danish Firms Starved of Labor
Sector Update: Health Care Stocks Decline Monday Afternoon
Novo-Nordisk A/S (NVO.US) invests 1.2 billion USD to build a factory for rare disease drugs in Denmark.
The Danish pharmaceutical company Novo-Nordisk A/S (NVO.US) announced on Monday that it will invest 8.5 billion kroner (approximately 1.2 billion USD) to build a new factory in Odense, Denmark, for the production of drugs for rare diseases. The company stated that construction work has already begun and is expected to be completed by 2027, at which time the facility is projected to create 400 permanent jobs.
Top Midday Stories: Honeywell Mulls Separation of Aerospace Business; Starbucks Expands Parental Leave for US Store Workers
Why the Investor Craze for Ozempic and Rival Weight-loss Drugs May Resume Next Year
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
Research finds that Novo-Nordisk A/S's (NVO.US) weight loss drugs may cause "blindness"; Danish regulatory authorities seek an investigation.
The Danish Pharmaceutical Agency stated that it will require European authorities to review two new studies indicating a link between Novo-Nordisk A/S's best-selling drug Ozempic and a rare loss of vision.
Novo Nordisk's Imminent Capacity Increase Is a Significant Positive -- Market Talk
Novo-Nordisk A/S (NVO.US) is investing 1.2 billion USD to build a new factory in Odense, Denmark, expected to be completed in 2027.
Novo-Nordisk A/S will invest 8.5 billion Danish Kroner (approximately 1.2 billion US dollars) to build a large factory in Denmark to meet the growing market demand for its blockbuster Pharmaceuticals.
Novo Nordisk to Invest $1.2 Billion in New Plant in Denmark
Express News | Market news: Novo-Nordisk A/S is investing 8.5 billion Danish kroner to establish a new production facility in Odense, Denmark.
Novo Nordisk Invests DKK 8.5 Billion in New Production Facility in Odense, Denmark
Express News | Novo-Nordisk A/S acquisition of Catalent Trade has been approved for completion.
Futu Morning News | Ready for the "Federal Reserve Decision Day"! More than 20 central banks from various countries will hold meetings this week; the adjustment of Nasdaq 100 constituents will take effect next week! Palantir and MSTR have been included.
This week's highlights from the Federal Reserve: There's no doubt about a rate cut in December, but January remains uncertain; Tesla's stock rose over 4% to a new high, and reports indicate that Trump's team is seeking to abolish the requirement for accident reports for autonomous vehicles.
Express News | Novo-Nordisk A/S: All regulatory completion conditions for Novo Holdings' acquisition of Cantel Medical for 16.5 billion USD have been met.
Key Deals for the Week: Patterson, Hershey & Mondelez, AIG & Nippon and More
Express News | Zhang Ligang from Ai Kang Group stated that most entrepreneurs are overweight because they lack time for exercise and drink a lot.